Anika Therapeutics (ANIK) Return on Capital Employed: 2011-2025
Historic Return on Capital Employed for Anika Therapeutics (ANIK) over the last 13 years, with Sep 2025 value amounting to -0.07%.
- Anika Therapeutics' Return on Capital Employed fell 16.00% to -0.07% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.07%, marking a year-over-year decrease of 16.00%. This contributed to the annual value of -0.02% for FY2024, which is 3.00% down from last year.
- According to the latest figures from Q3 2025, Anika Therapeutics' Return on Capital Employed is -0.07%, which was down 36.92% from -0.05% recorded in Q2 2025.
- In the past 5 years, Anika Therapeutics' Return on Capital Employed registered a high of 0.09% during Q3 2024, and its lowest value of -0.11% during Q1 2021.
- Its 3-year average for Return on Capital Employed is -0.01%, with a median of -0.02% in 2023.
- As far as peak fluctuations go, Anika Therapeutics' Return on Capital Employed decreased by 21bps in 2021, and later increased by 12bps in 2024.
- Over the past 5 years, Anika Therapeutics' Return on Capital Employed (Quarterly) stood at 0.01% in 2021, then remained steady at 0.01% in 2022, then declined by 1bps to 0.00% in 2023, then fell by 3bps to -0.03% in 2024, then decreased by 16bps to -0.07% in 2025.
- Its Return on Capital Employed was -0.07% in Q3 2025, compared to -0.05% in Q2 2025 and -0.04% in Q1 2025.